Joshua Gruber

Joshua Gruber specializes in the diagnosis and treatment of rare T-cell and NK/T-cell lymphomas in the United States, where this disease is less common than in Asia. His work addresses optimal administration of asparaginase-based regimens in Western patients, toxicity management including pancreatitis and coagulopathy, and the integration of radiation therapy. He participates in the NK/T-cell Lymphoma Consortium and multi-site rare lymphoma registries.